Chemicea Pharmaceuticals
Chemicea Pharmaceuticals, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. Founded in 2010, the company has established a strong presence in key operational regions, including Asia and Europe, and has achieved significant milestones in research and development. With a focus on innovation, Chemicea offers a diverse range of products that cater to various therapeutic areas, including oncology, cardiology, and neurology. Their commitment to quality and sustainability sets them apart in a competitive market. Recognised for their robust supply chain and regulatory compliance, Chemicea Pharmaceuticals continues to strengthen its market position, contributing to advancements in healthcare and patient outcomes globally.
DitchCarbon Score
How does Chemicea Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chemicea Pharmaceuticals's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chemicea Pharmaceuticals's reported carbon emissions
Chemicea Pharmaceuticals, headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is essential to highlight the company's commitment to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed, indicating a potential area for future development in their sustainability strategy. As the pharmaceutical industry increasingly prioritises environmental responsibility, Chemicea Pharmaceuticals may benefit from establishing clear emissions reduction goals and aligning with industry standards to enhance its climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chemicea Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
